, Volume 80, Issue 2, pp 288-290

Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Preliminary research suggests that naloxone (Narcan), a short-acting opiate antagonist, could be provided by prescription or distribution to heroin users to reduce the likelihood of fatality from overdose. We conducted a random postal survey of 1.100 prescription-authorized health care providers in New York City to determine willingness to prescribe naloxone to patients at risk of an opiate overdose. Among 363 nurse practitioners, physicians, and physician assistants responding, 33,4% would consider prescribing naloxone, and 29.4% were unsure. This preliminary study suggests that a substantial number of New York City health care providers would prescribe naloxone for opiate overdose prevention.